AGM Trading Update

By

Regulatory News | 18 Apr, 2023

Updated : 14:52

RNS Number : 5007W
Porvair PLC
18 April 2023
 

For immediate release                                                                                                18 April 2023

Porvair plc ("Porvair" or the "Group")

 

AGM Trading Update

Porvair plc, the specialist filtration, laboratory and environmental technology group, will make the following trading statement at its Annual General Meeting later today at 11:00 a.m.:

In the four months ended March 2023, like-for-like constant currency revenue growth was 8%. Order lead times are shortening to more normal levels as supply chain disruption eases, notably in Laboratory and certain Industrial segments. The Group order book is however currently higher than in all previous years.

The Group will announce its interim results for the six months ending 31 May 2023 on Monday 3 July 2023.

For more information, contact:

 

Porvair plc


Ben Stocks, Chief Executive

01553 765 500

James Mills, Group Finance Director

01553 765 500



Buchanan Communications

0207 466 5000

Charles Ryland / Simon Compton / Harry Swinburne


 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses.  Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAPLXFEDDEFA

Last news